Travere Therapeutics, Inc. (TVTX) vs Waystar Holding Corp. (WAY)
A side-by-side comparison of Travere Therapeutics, Inc. and Waystar Holding Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
TVTX
Travere Therapeutics, Inc.
$55.98HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
WAY
Waystar Holding Corp.
$26.40HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — TVTX vs WAY
growth of $100 · dividends reinvested · last 2yTVTX +697.6% (+182.4%/yr)WAY +27.9% (+13.1%/yr)TVTX compounded faster over this window
Log scale — wide-divergence pair
TVTX WAY
TVTX vs WAY: by the numbers
- •TVTX is the larger company ($5.21B vs $5.06B market cap).
- •WAY is profitable (11.18% net margin) while TVTX runs a net loss (-7.35%).
Metrics side by side
Valuation
| Metric | TVTX | WAY |
|---|---|---|
| P/E ratio | N/A | 37.71 |
| Forward P/E | N/A | 15.81 |
| P/S ratio | 8.80 | 4.20 |
| P/B ratio | 212.29 | 1.27 |
| EV / EBITDA | 248.98 | 15.10 |
| FCF yield | 0.99% | 4.86% |
Profitability
| Metric | TVTX | WAY |
|---|---|---|
| Gross margin | 94.41% | 69.11% |
| Operating margin | -6.84% | 22.87% |
| Net margin | -7.35% | 11.18% |
| ROE | -177.24% | 3.38% |
| ROIC | -6.19% | 3.38% |
Growth (annualized)
| Metric | TVTX | WAY |
|---|---|---|
| Revenue CAGR (5Y) | 23.71% | N/A |
| Total return CAGR (5Y) | 17.83% | N/A |
Frequently asked
- Is TVTX or WAY more profitable?
- WAY runs the higher net margin — TVTX at -7.35% versus WAY at 11.18%.
Go deeper
Dig into the metrics
Waystar P/E ratioTravere Therapeutics ROEWaystar ROETravere Therapeutics operating marginWaystar operating marginTravere Therapeutics revenue growthWaystar revenue growthTravere Therapeutics free cash flowWaystar free cash flow
Travere Therapeutics & Waystar appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.